日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The oncolytic adenovirus Ad-TD-nsIL12 in primary or progressive pediatric IDH wild-type diffuse intrinsic pontine glioma results of two phase I clinical trials.

溶瘤腺病毒 Ad-TD-nsIL12 治疗原发性或进展性儿童 IDH 野生型弥漫性内生性脑桥胶质瘤的两项 I 期临床试验结果

Qian Xiao, Ning Weihai, Yang Jingjing, Dunmall Louisa Chard, Pandha Hardev S, Shang Guanjie, Guo Yuduo, Zhang Dongxu, Qu Yanming, Wang Haoran, Gu Chunyu, Zhang Mingshan, Wang Yaohe, Wang Shengdian, Zhang Hongwei

Non-secreting IL12 expressing oncolytic adenovirus Ad-TD-nsIL12 in recurrent high-grade glioma: a phase I trial

不分泌 IL12 表达溶瘤腺病毒 Ad-TD-nsIL12 在复发性高级别胶质瘤中的应用:一项 I 期试验

Weihai Ning #, Xiao Qian #, Louisa Chard Dunmall, Funan Liu, Yuduo Guo, Shenglun Li, Dixiang Song, Deshan Liu, Lixin Ma, Yanming Qu, Haoran Wang, Chunyu Gu, Mingshan Zhang, Yaohe Wang, Shengdian Wang, Hongwei Zhang

Epithelial-mesenchymal transition is the main way in which glioma-associated microglia/macrophages promote glioma progression

上皮-间质转化是胶质瘤相关小胶质细胞/巨噬细胞促进胶质瘤进展的主要途径。

He, Xin; Guo, Yuduo; Yu, Chunjiang; Zhang, Hongwei; Wang, Shengdian

A preliminary study on serological assay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 238 admitted hospital patients

一项针对238名住院患者严重急性呼吸综合征冠状病毒2 (SARS-CoV-2) 血清学检测的初步研究

Liu, Lei; Liu, Wanbing; Zheng, Yaqiong; Jiang, Xiaojing; Kou, Guomei; Ding, Jinya; Wang, Qiongshu; Huang, Qianchuan; Ding, Yinjuan; Ni, Wenxu; Wu, Wanlei; Tang, Shi; Tan, Li; Hu, Zhenhong; Xu, Weitian; Zhang, Yong; Zhang, Bo; Tang, Zhongzhi; Zhang, Xinhua; Li, Honghua; Rao, Zhiguo; Jiang, Hui; Ren, Xingfeng; Wang, Shengdian; Zheng, Shangen

A novel workflow for cancer blood biomarker identification

一种用于癌症血液生物标志物鉴定的新型工作流程

Wang, Xiang; Qiu, Zhiqiang; Ji, Xiangwen; Ning, Weihai; An, Yihua; Wang, Shengdian; Zhang, Hongwei

Arthritis of large joints shown as a rare clinical feature of cytokine release syndrome after chimeric antigen receptor T cell therapy: A case report

嵌合抗原受体T细胞治疗后细胞因子释放综合征罕见临床表现:大关节炎:病例报告

Wang, Li-Xin; Chen, Xiaoping; Jia, Mingming; Wang, Shengdian; Shen, Jianliang

Re-designing Interleukin-12 to enhance its safety and potential as an anti-tumor immunotherapeutic agent

重新设计白细胞介素-12,以提高其作为抗肿瘤免疫治疗剂的安全性和潜力

Wang, Pengju; Li, Xiaozhu; Wang, Jiwei; Gao, Dongling; Li, Yuenan; Li, Haoze; Chu, Yongchao; Zhang, Zhongxian; Liu, Hongtao; Jiang, Guozhong; Cheng, Zhenguo; Wang, Shengdian; Dong, Jianzeng; Feng, Baisui; Chard, Louisa S; Lemoine, Nicholas R; Wang, Yaohe

Hyper-IL-15 suppresses metastatic and autochthonous liver cancer by promoting tumour-specific CD8+ T cell responses

高IL-15通过促进肿瘤特异性CD8+ T细胞反应来抑制转移性和原发性肝癌。

Cheng, Liang; Du, Xuexiang; Wang, Zheng; Ju, Jianqi; Jia, Mingming; Huang, Qibin; Xing, Qiao; Xu, Meng; Tan, Yi; Liu, Mingyue; Du, Peishuang; Su, Lishan; Wang, Shengdian

Immunotherapy of metastatic and autochthonous liver cancer with IL-15/IL-15Rα fusion protein

利用IL-15/IL-15Rα融合蛋白进行转移性和原发性肝癌的免疫治疗

Cheng, Liang; Du, Xuexiang; Su, Lishan; Wang, Shengdian

IL-21 accelerates xenogeneic graft-versus-host disease correlated with increased B-cell proliferation

IL-21加速异种移植物抗宿主病,这与B细胞增殖增加相关。

Wu, Xiaoran; Tan, Yi; Xing, Qiao; Wang, Shengdian